﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Nickan Research Institute</PublisherName>
      <JournalTitle>Journal of Parathyroid Disease</JournalTitle>
      <Issn>2345-6558</Issn>
      <Volume>10</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2022</Year>
        <Month>01</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Interference caused by anti-streptavidin antibodies in a parathyroid hormone assay; a case report</ArticleTitle>
    <FirstPage>e6134</FirstPage>
    <LastPage>e6134</LastPage>
    <ELocationID EIdType="doi">10.34172/jpd.2022.6134</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Benjamin Siegfried</FirstName>
        <LastName>Trautz</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-5330-5957</Identifier>
      </Author>
      <Author>
        <FirstName>Thomas</FirstName>
        <LastName>Negele</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/jpd.2022.6134</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2021</Year>
        <Month>07</Month>
        <Day>02</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2021</Year>
        <Month>07</Month>
        <Day>31</Day>
      </PubDate>
    </History>
    <Abstract>Endogenous antibodies can lead to test interference in streptavidin-biotin based laboratory assays, such as thyroid function tests or parathyroid hormone (PTH) levels. We report about a patient, who presented for thyroid surgery, showing undetectable PTH levels despite normocalcaemia in internally assessed preoperative laboratory work. Previously, anti-streptavidin antibodies were detected in the patient’s blood and normal PTH levels could be measured in a streptavidin-free assay. To our knowledge this is the first reported case of a clinically relevant PTH test interference due to endogenous anti-streptavidin antibodies, thus complicating the evaluation of postoperative hypoparathyroidism.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">PTH</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Anti-streptavidin</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Thyroid surgery</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Hypoparathyroidism</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Interference</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">TSH</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>